Terms: = Germ cell tumor AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Clinical Outcome
242 results:
1. PATIENT-RELATED FACTORS AND clinical MANAGEMENT outcomeS OF RETINOBLASTOMA IN CALABAR, NIGERIA.
Nkanga ED; Nlemadim AC; Arazi M; Nkanga DG; Duke RE; Fabian ID; Nkanga ED; Odey FA; Meremikwu MM
West Afr J Med; 2023 Dec; 40(12 Suppl 1):S36-S37. PubMed ID: 38070170
[TBL] [Abstract] [Full Text] [Related]
2. Whole-exome sequencing reveals mutational profiles of anorectal and gynecological melanoma.
Sun W; Liu K; Zhou H; Zhao F; Dong Y; Xu Y; Kong Y; Wang M; Cheng X; Chen Y
Med Oncol; 2023 Oct; 40(11):330. PubMed ID: 37831226
[TBL] [Abstract] [Full Text] [Related]
3. Role of gene sequencing in classifying struma ovarii: BRAF p.G469A mutation and TERT promoter alterations favour malignant struma ovarii.
Neyrand S; Trecourt A; Lopez J; Just PA; Descotes F; Borson-Chazot F; Ray-Coquard I; Decaussin-Petrucci M; Devouassoux-Shisheboran M
Histopathology; 2024 Jan; 84(2):291-300. PubMed ID: 37771077
[TBL] [Abstract] [Full Text] [Related]
4. clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome.
Kolodziejczak AS; Guerrini-Rousseau L; Planchon JM; Ecker J; Selt F; Mynarek M; Obrecht D; Sill M; Autry RJ; Stutheit-Zhao E; Hirsch S; Amouyal E; Dufour C; Ayrault O; Torrejon J; Waszak SM; Ramaswamy V; Pentikainen V; Demir HA; Clifford SC; Schwalbe EC; Massimi L; Snuderl M; Galbraith K; Karajannis MA; Hill K; Li BK; Walsh M; White CL; Redmond S; Loizos L; Jakob M; Kordes UR; Schmid I; Hauer J; Blattmann C; Filippidou M; Piccolo G; Scheurlen W; Farrag A; Grund K; Sutter C; Pietsch T; Frank S; Schewe DM; Malkin D; Ben-Arush M; Sehested A; Wong TT; Wu KS; Liu YL; Carceller F; Mueller S; Stoller S; Taylor MD; Tabori U; Bouffet E; Kool M; Sahm F; von Deimling A; Korshunov A; von Hoff K; Kratz CP; Sturm D; Jones DTW; Rutkowski S; van Tilburg CM; Witt O; Bougeard G; Pajtler KW; Pfister SM; Bourdeaut F; Milde T
Neuro Oncol; 2023 Dec; 25(12):2273-2286. PubMed ID: 37379234
[TBL] [Abstract] [Full Text] [Related]
5. BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors.
Mandalà M; Palmieri G; Ludovini V; Baglivo S; Marasciulo F; Castiglione F; Gili A; Osella Abate S; Rubatto M; Senetta R; Avallone G; Ribero S; Romano L; Pimpinelli N; de Giorgi V; Roila F; Pisano M; Casula M; Manca A; Sini MC; Massi D; Quaglino P;
J Eur Acad Dermatol Venereol; 2023 Oct; 37(10):1991-1998. PubMed ID: 37335879
[TBL] [Abstract] [Full Text] [Related]
6. Ganglioneuroblastoma intermixed: Clinicopathological implications of diagnosis at presentation and genomic correlations.
Nezami BG; Modak S; Cardenas FI; Sarungbam J; Sirintrapun SJ; Gopalan A; Chen Y; Al-Ahmadie H; Fine SW; Reuter VE; Tickoo SK
Pediatr Blood Cancer; 2023 Aug; 70(8):e30434. PubMed ID: 37243318
[TBL] [Abstract] [Full Text] [Related]
7. clinical and imaging findings for the evaluation of large Rathke's cleft cysts and cystic craniopharyngiomas.
Yang CH; Wu CH; Lin TM; Chen ST; Tai WA; Yu KW; Luo CB; Lirng JF; Chang FC
Pituitary; 2023 Aug; 26(4):393-401. PubMed ID: 37227614
[TBL] [Abstract] [Full Text] [Related]
8. Real-world clinical outcome and safety of adjuvant therapy in stage III melanoma patients: Data from two Academic Italian Institutions.
De Falco V; Suarato G; Napolitano R; Argenziano G; Famiglietti V; Amato A; Servetto A; Bianco R; Formisano L; Terrano V; Esposito A; Giugliano MC; Ciardiello D; Ciardiello F; Napolitano S; Troiani T
Int J Cancer; 2023 Jul; 153(1):133-140. PubMed ID: 36752579
[TBL] [Abstract] [Full Text] [Related]
9. Combined PD-1, BRAF and MEK inhibition in BRAF
Tian J; Chen JH; Chao SX; Pelka K; Giannakis M; Hess J; Burke K; Jorgji V; Sindurakar P; Braverman J; Mehta A; Oka T; Huang M; Lieb D; Spurrell M; Allen JN; Abrams TA; Clark JW; Enzinger AC; Enzinger PC; Klempner SJ; McCleary NJ; Meyerhardt JA; Ryan DP; Yurgelun MB; Kanter K; Van Seventer EE; Baiev I; Chi G; Jarnagin J; Bradford WB; Wong E; Michel AG; Fetter IJ; Siravegna G; Gemma AJ; Sharpe A; Demehri S; Leary R; Campbell CD; Yilmaz O; Getz GA; Parikh AR; Hacohen N; Corcoran RB
Nat Med; 2023 Feb; 29(2):458-466. PubMed ID: 36702949
[TBL] [Abstract] [Full Text] [Related]
10. Discovery of pathway-independent protein signatures associated with clinical outcome in human cancer cohorts.
Konaté MM; Li MC; McShane LM; Zhao Y
Sci Rep; 2022 Nov; 12(1):19283. PubMed ID: 36369472
[TBL] [Abstract] [Full Text] [Related]
11. TSPO PET signal using [
Quach S; Holzgreve A; Kaiser L; Unterrainer M; Dekorsy FJ; Nelwan DV; Bartos LM; Kirchleitner SV; Weller J; Weidner L; Niyazi M; Ruf VC; Herms J; Stöcklein S; Wetzel C; Riemenschneider MJ; V Baumgarten L; Thon N; Brendel M; Rupprecht R; Bartenstein P; Tonn JC; Albert NL
Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):859-869. PubMed ID: 36329288
[TBL] [Abstract] [Full Text] [Related]
12. Functional outcomes, extent of resection, and bright/vague fluorescence interface in resection of glioblastomas involving the motor pathways assisted by 5-ALA.
Muscas G; Orlandini S; Bonaudo C; Dardo M; Esposito A; Campagnaro L; Carrai R; Fainardi E; Ciccarino P; Della Puppa A
Acta Neurochir (Wien); 2022 Dec; 164(12):3267-3274. PubMed ID: 36087121
[TBL] [Abstract] [Full Text] [Related]
13. Postoperative magnetic resonance imaging signal changes in middle cerebral peduncle after vestibular schwannoma surgery.
Peto I; Noureldine MHA; Zavadskiy G; Pressman E; Flores-Milan G; van Loveren H; Agazzi S
Br J Neurosurg; 2022 Dec; 36(6):712-719. PubMed ID: 35913025
[TBL] [Abstract] [Full Text] [Related]
14. Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker outcomes from PNOC003.
Kline C; Jain P; Kilburn L; Bonner ER; Gupta N; Crawford JR; Banerjee A; Packer RJ; Villanueva-Meyer J; Luks T; Zhang Y; Kambhampati M; Zhang J; Yadavilli S; Zhang B; Gaonkar KS; Rokita JL; Kraya A; Kuhn J; Liang W; Byron S; Berens M; Molinaro A; Prados M; Resnick A; Waszak SM; Nazarian J; Mueller S
Clin Cancer Res; 2022 Sep; 28(18):3965-3978. PubMed ID: 35852795
[TBL] [Abstract] [Full Text] [Related]
15. Molecular mechanisms underlying the development of neuroendocrine prostate cancer.
Liu S; Alabi BR; Yin Q; Stoyanova T
Semin Cancer Biol; 2022 Nov; 86(Pt 3):57-68. PubMed ID: 35597438
[TBL] [Abstract] [Full Text] [Related]
16. Boron Neutron Capture Therapy (BNCT) for Cutaneous Malignant Melanoma Using
Fukuda H
Cells; 2021 Oct; 10(11):. PubMed ID: 34831103
[TBL] [Abstract] [Full Text] [Related]
17. Thalamic gliomas in adults: a systematic review of clinical characteristics, treatment strategies, and survival outcomes.
Palmisciano P; El Ahmadieh TY; Haider AS; Bin Alamer O; Robertson FC; Plitt AR; Aoun SG; Yu K; Cohen-Gadol A; Moss NS; Patel TR; Sawaya R
J Neurooncol; 2021 Dec; 155(3):215-224. PubMed ID: 34797525
[TBL] [Abstract] [Full Text] [Related]
18. Identification of novel RB1 genetic variants in Retinoblastoma patients and their impact on clinical outcome.
Manukonda R; Pujar A; Ramappa G; Vemuganti GK; Kaliki S
Ophthalmic Genet; 2022 Feb; 43(1):64-72. PubMed ID: 34645364
[TBL] [Abstract] [Full Text] [Related]
19. Vitamin D deficiency and tumor aggressiveness in gastroenteropancreatic neuroendocrine tumors.
Altieri B; Barrea L; Modica R; Bottiglieri F; de Cicco F; Muscogiuri G; Circelli L; Savarese G; Di Somma C; Savastano S; Colao A; Faggiano A
Endocrine; 2022 Feb; 75(2):623-634. PubMed ID: 34533768
[TBL] [Abstract] [Full Text] [Related]
20. Selective Inhibitors of Histone Deacetylase 10 (HDAC-10).
Pojani E; Barlocco D
Curr Med Chem; 2022; 29(13):2306-2321. PubMed ID: 34468295
[TBL] [Abstract] [Full Text] [Related]
[Next]